OpenAlex
PricingAboutJobs
Log inGet started
Work

CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

HTML

Year: 2026
Type: review
Source: Clinical & Translational Oncology
DOI: 10.1007/s12094-025-04213-4
Authors: Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi, Priya Priyadarshini Nayak, J. Bethanney Janney, Gurjant Singh, Djamila Polatova, Hayder Naji Sameer, Rasim M. Salih, Mohaned Adil
Institutions: Ahl Al Bayt University, Jain University, Siksha O Anusandhan University, Institute of Medical Sciences and Sum Hospital, Sathyabama Institute of Science and Technology, Chandigarh University, National University of Science and Technology, Al-Zahrawi University, Al-Farahidi University
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: CTLA-4, prostate cancer, immune checkpoint inhibitors, immunotherapy, anti-CTLA-4 monoclonal antibody, T cell regulation, tumor immunosuppression
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7127038530
FWCI: 0.746
Cites: 143
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms